project id: TCGA-OV; case submitter id: TCGA-13-2060; selected normal wgs: true; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 0.5; rna integrity number: 7.4; spectrophotometer method: UV Spec; age at index: 51; days to birth: -18635; ethnicity: not reported; gender: female; race: white; vital status: Alive; year of birth: 1958; age at diagnosis: 18635; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2369.0; figo stage: Stage IV; icd 10 code: C56.9; last known disease status: not reported; morphology: 8441/3; primary diagnosis: Serous cystadenocarcinoma, NOS; prior malignancy: not reported; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Ovary; synchronous malignancy: Not Reported; tissue or organ of origin: Ovary; tumor grade: Not Reported; year of diagnosis: 2009; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; intermediate dimension: 1.5; longest dimension: 2.5; preservation method: Unknown; shortest dimension: 0.5; sample id: bffd965b-885f-4914-b25b-a993338acaad; sample submitter id: TCGA-13-2060-01A; portion id: 66095e77-a7e7-41e0-a61d-8debcedb1105; portion submitter id: TCGA-13-2060-01A-01; percent monocyte infiltration: 0.0; percent necrosis: 5.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 85.0;